The findings from the present study showed that in patients with severe COVID-19, neopterin, CRP, albumin, the CRP-to-albumin ratio, the neutrophil/lymphocyte ratio, the platelet/lymphocyte ratio, and the lymphocyte/monocyte ratio could be potential parameters for indicating inflammation in patients with severe COVID-19. This evidence concerns the gene ALB and COVID-19.